Intelligent Bio Solutions raises $3.8M via warrant exercise inducement, funds FDA 510k filing

INTELLIGENT BIO SOLUTIONS INC.

Gross proceeds of ~$3.8M from exercise of existing Series G and H-1 warrants at $1.90/share; closing July 28, 2025.
Holders get new Series J warrants for up to 4,046,456 shares at $1.90, exercisable upon stockholder approval, expiring 5.5 years from issuance.
Net proceeds to fund completion of 510k filing with FDA for Fingerprint Drug Screening System and general working capital.
Company issued 1,545,494 common shares via warrant exercise and amended H-1 warrants for 477,734 shares at $0.01/share.
Outstanding shares as of July 24, 2025: 7,433,658, including recent ATM and restricted stock issuances.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.